- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Debra Patt Acknowledges Progress Made Against Cancer
One of the important findings from the American Society of Clinical Oncology’s report is that cancer mortality has gone down, said Debra Patt, MD, MPH, MBA, director of public policy at Texas Oncology.
One of the important findings from the American Society of Clinical Oncology (ASCO)’s report is that cancer mortality has gone down, said Debra Patt, MD, MPH, MBA, director of public policy at Texas Oncology.
Transcript (slightly modified)
What were some of the key findings from ASCO’s annual report on the state of cancer care in the United States?
Well, I think one of the most important things that we recognize today is that while we’re seeing more cancer, cancer mortality continues to go down. So one of the findings in the report was that cancer mortality, in fact, has gone down by 1.5% per year for the last decade. I think that’s representative of progress: progress in screening and early detection, progress in more effective immediate therapies, progress in long-term therapies, and even in patients with incurable illness that they live longer. Those are great successes.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Semaglutide Eligibility Expands to Over Half of US Adults
November 21st 2024Over half of the US adult population may benefit from semaglutide, a drug primarily used for weight loss and diabetes, although concerns about access and cost persist, especially considering its potential for wider health applications.
Read More
